KNSA Kiniksa Pharmaceuticals Ltd: Narxning prognoz qilingan daromadga nisbati

Ommaviy kompaniya Kiniksa Pharmaceuticals (KNSA) logotipi

Kiniksa Pharmaceuticals (KNSA) kompaniyasining strategik maqsadi o'zining monopol dori vositasi ARCALYST orqali takrorlanuvchi perikardit davolashda ustunlikka erishishdir. GURU.Markets grafigidagi prognoz qilingan sotuvlarga nisbatan narx koeffitsiyenti ushbu maqsad sari yo'lni ko'rsatadi, bunda 5.60 ushbu metrikaning joriy darajasini ifodalaydi. Kam uchraydigan kasalliklar terapiyasi uchun yuqori narxlar va patent himoyasi bozor to'siqlarini yaratadi, o'sish esa faqat yangi molekulalarning litsenziyalanishiga bog'liq.

Kiniksa - KNSA Kapitalizatsiyaning kutilayotgan sotuvga nisbati (davr: 04.07.2022 - 15.11.2026)

Kiniksa Pharmaceuticals kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning fundamental tahlili:KNSA (Kiniksa Corp)
Kiniksa Pharmaceuticals tovar namunasi

Forward P/S biznesning bozor qiymatini kutilayotgan daromadga nisbatan baholaydi, bu esa investorga tebranishlar davrida kelajakdagi pul oqimlari uchun qanchalik ortiqcha to'lov qilinganini aniqlash imkonini beradi. Prognoz qilingan P/S koeffitsiyentini tahlil qilish orqali Kiniksa Pharmaceuticals (KNSA) ning antitellar patent himoyasi va biotexnologiya sohasidagi monopoliya maqomi joriy kapitalizatsiyani oqlash-oklamasligini baholash hamda kompaniyaning fundamental barqarorligini tasdiqlash mumkin.

Raqobatdosh kompaniyalar tahlili

Forvard P/S multiplikatori ARGX (argenx.com)|BioNTech Group (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ABIVAX - Forvard P/S multiplikatori|ADMA - Forvard P/S multiplikatori|Protagonist (PTGX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Immunovant Inc|GRFS (Grifols Biemat) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Adaptive Biotechnologies Inc.|Narxning prognoz qilingan daromadga nisbati Celldex Therapeutics (CLDX)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati auriniapharma.com|Narxning prognoz qilingan daromadga nisbati BioCryst Pharmaceuticals BCRX|Sotuvga nisbatan forvard narx VERA|Dianthus Pharma - Forvard P/S multiplikatori|PHVS - Forvard P/S multiplikatori|ABCL: Forvard P/S multiplikatori|TRML (Tourmaline Bio, Inc.) - Narxning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Intrexon|PHAR - Prognoz narxning daromadga nisbati|Forvard P/S multiplikatori NKTR|Narxning prognoz qilingan daromadga nisbati UPB (Upstream Bio Corp)|Narxning prognoz qilingan daromadga nisbati Zenas Biopharma, Inc. ZBIO|Kapitalizatsiyaning kutilayotgan sotuvga nisbati immunome.com (IMNM)|Gossamer Bio Inc - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx KALV (KalVista Pharmaceuticals, Inc.)|SEPN: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Pieris Pharmaceuticals Inc|Forvard narx/daromad multiplikatori SVRA|Forvard narx/daromad multiplikatori Rigel Pharmaceuticals (RIGL)|Forvard P/S multiplikatori ANAB|ATXS - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati enGene Corp ENGN|Kapitalizatsiyaning kutilayotgan sotuvga nisbati RAPT Therapeutics, Inc. (RAPT)|Aerovate - Forvard P/S multiplikatori|ACRS - Forvard P/S multiplikatori|KYTX (Kyverna Therapeutics) - Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Tiziana Life Sciences Ltd. (TLSA)|Forvard narx/daromad multiplikatori CABA|Ventyx Biosciences (VTYX) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori THTX|AVTX (Avalo Therapeutics, Inc) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ELDN (eledon.com)|AGEN - Forvard narx/daromad multiplikatori|CLYM - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati ZURA|ATYR: Forvard P/S multiplikatori|Adagene Corp (ADAG) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori IMA|Shattuck Labs, Inc. - Kelajakdagi narxning daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Equillium Inc (EQ)|Forvard P/S multiplikatori Connect Biopharma Holdings (CNTB)|Narxning prognoz qilingan daromadga nisbati Immunic, Inc. IMUX|Forvard P/S multiplikatori Atara Biotherapeutics ATRA|IFRX - Narxning prognoz qilingan daromadga nisbati|XFOR: Narxning prognoz qilingan daromadga nisbati|ACET: Forvard P/S multiplikatori|CELU - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati inmunebio.com|Kapitalizatsiyaning prognoz qilingan daromadga nisbati BRNS (barinthusbio.com)|Forvard P/S multiplikatori KZR|Forvard P/S multiplikatori SAB Biotherapeutics, Inc (SABS)|Forvard P/S multiplikatori AKTX (Akari Therapeutics, Plc)|Forvard P/S multiplikatori enlivex.com ENLV|QTTB: Forvard narx/daromad multiplikatori|GOVX - Forvard P/S multiplikatori|Edesa Biotech Inc (EDSA) - Narxning prognoz qilingan daromadga nisbati|IBIO - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati carismatx.com|XTLB: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati aptevotherapeutics.com APVO|AIM - Forvard narx/daromad multiplikatori|Aditxt - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati GRI Bio Corporation GRI|xortx.com (XRTX) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati reshapelifesciences.com (HIND)|Narxning prognoz qilingan daromadga nisbati Revelation Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Indaptus Therapeutics, Inc. INDP|Narxning prognoz qilingan daromadga nisbati BiondVax Pharmaceuticals (SCNI)|Forvard narx/daromad multiplikatori CalciMedica CALI|Narxning prognoz qilingan daromadga nisbati Affimed AFMD|ALLK - Forvard narx/daromad multiplikatori|HOOKIPA Pharma, Inc. - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx IGMS (igmbio.com)|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|Ocean Biomedical Corp (OCEA) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Forvard P/S multiplikatori thirdharmonicbio.com